Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Deborah K. Douglas"'
Autor:
Daniel A. Hussar, Deborah K. Douglas
Publikováno v:
Journal of the American Pharmacists Association : JAPhA. 57(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c12491849e1b324f7b872a15ebf3de82
https://pubmed.ncbi.nlm.nih.gov/28506401
https://pubmed.ncbi.nlm.nih.gov/28506401
Autor:
Margaret A, Fonder, Deborah K, Douglas
Publikováno v:
Cutis. 81(6)
Cutaneous angiosarcoma is a rare malignant vascular tumor with a poor prognosis, most commonly affecting elderly white men. Diagnosis usually is delayed because the tumor has a highly variable and often innocuous presentation. Cutaneous angiosarcoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1170b6301c3884f23ed617070f30ffb3
https://pubmed.ncbi.nlm.nih.gov/18666387
https://pubmed.ncbi.nlm.nih.gov/18666387
Autor:
Mary B. Leatherbarrow, Deborah K. Douglas, Robert J. Eckrich, M. L. Baldwin, Susan S. Esty, Patricia A. Collins, Paul M. Ness, Sandra S. Ellisor
Publikováno v:
Immunohematology. 4:71-74
An alloantibody to a high-incidence antigen, associated with multiple other alloantibodies, made it impossible to supply antigen-negative red blood cells (RBCs) for a chronically transfused sickle cell anemia patient. Anti-Cra,-E,K,-S, -Fya, -Fyb, as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce61a0a4de7837bbd6aba1fee30047f0
https://doi.org/10.21307/immunohematology-2019-1108
https://doi.org/10.21307/immunohematology-2019-1108
Autor:
Frans Peetoom, S. Gerald Sandler, Gerald Shulman, Robert J. Bowman, Roger Y. Dodd, C. T. Fang, Bernard J. Poiesz, Steven H. Kleinman, W. Frederick Darr, Alan E. Williams, Bruce A. Lenes, Eoline I. McGowan, Deborah K. Douglas, Dennis J. Slamon
Publikováno v:
Science (New York, N.Y.). 240(4852)
Screening for human T-lymphotropic virus type I (HTLV-I) antibodies was performed on sera from 39,898 blood donors at eight blood centers in geographically distinct areas of the United States. Ten donors (0.025 percent) showed evidence of HTLV-I sero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f67889ea7521c7ccb8e5156fa5d8e9bb
https://pubmed.ncbi.nlm.nih.gov/2896386
https://pubmed.ncbi.nlm.nih.gov/2896386
Publikováno v:
Transfusion. 25:179-179
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7da6e7ab883bc4864cfeb653455880ce
https://doi.org/10.1046/j.1537-2995.1985.25285169218.x
https://doi.org/10.1046/j.1537-2995.1985.25285169218.x